EBT Medical Competitors and Similar CompaniesClear all

EBT Medical's competitors and similar companies include Respicardia, Tao Technologies, NeurAxis and Tactile Medical.

	EBT Medical EBT Medical develops neuromodulation technologies that restore control, dignity, and independence to people suffering from pelvic floor disorders.	Respicardia Respicardia develops implantable therapies to improve respiratory and cardiovascular health.	Tao Technologies Tao Technologies is a provider of healthcare technology solutions.	NeurAxis NeurAxis (formerly known as Innovative Health Solutions) is a company that develops medical devices to reduce the symptoms of opioid withdrawal.	Tactile Medical Tactile Medical is advancing the standard of care in treating chronic diseases at home.
Founding Date	Founding Date 2014	Founding Date 2006	Founding Date 2012	Founding Date 2011	Founding Date 2006
Type	Type Private	Type Subsidiary	Type Private	Type Public	Type Public
Tags	Tags Healthcare healthtech medical devices therapy	Tags Healthcare healthtech medical devices therapy	Tags Healthcare healthtech medical devices therapy	Tags Healthcare healthtech medical devices therapy	Tags Healthcare healthtech medical devices therapy
Locations	Locations Toronto, CA HQ Hopkinton, US	Locations Hopkins, US HQ	Locations Cittadella, IT HQ	Locations Carmel, US HQ	Locations Minneapolis, US HQ
Employees	Employees 12	Employees 94	Employees 225% increase	Employees 16	Employees 62926% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 20.4 m	Valuation ($) 346.8 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $3.6m (FY, 2025)	Revenue (est.) $329.5m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $562.9k (FY, 2025)	Cost of goods $79.4m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit $3m (FY, 2025)	Gross profit $250.1m (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income ($7.8m) (FY, 2025)	Net income $19.1m (FY, 2025)
Funding
Total funding raised	Total funding raised $ 10m	Total funding raised $ 149.1m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 23.2m